T21 is a Success for Sequenom
Instrument Market to Reach $45 Billion by 2016
Illumina Says “No” To Roche
Growth for San Diego Life Science
Top Healthcare, Biotech Employers for 2012
Back in October 2011, Sequenom – a life sciences and genetic analysis solutions company based out of San Diego, California – announced that it would launch their MaterniT21 test for Down Syndrome. Following the announcement, some experts in the industry heralded the test as a potential game-changer for non-invasive testing....
According to a newly published report from MarketResearch.com, the global life science chemical and instrumentation market is set to grow from $30 billion in 2011 to $45 billion by 2016. For the global instrument market, the report goes on to state that spectrometry represented the largest segment within this market,...
After a few weeks of anxious waiting, new updates have surfaced regarding the much-discussed hostile takeover bid of next generation sequencing giant, Illumina. According to reports, Illumina’s board of directors rejected Roche’s bid to acquire the company, calling the move “blatantly opportunistic” and an unfair. Illumina’s board elaborated on this...
A new report shows that the San Diego biotech industry continues to experience steady growth in both the jobs sector and business sector, despite persistent economic troubles. The new information comes courtesy of BIOCOM, the largest regional life science association in the world. In their new report, the organization states...
CNN, Fortune, and Money have just posted their collective list of the 100 Best Companies to Work for in 2012. This year, 15 healthcare and biotech companies made the list, the highest ranking of which was CHG Healthcare Services at #9. CHG ranked #27 in the previous year, so this...